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Abstract
Background: Knowledge on the etiology of LRTIs is essential for improvement of the clinical diagnosis and
accurate treatment. Molecular detection methods were applied to identify a broad range of bacterial and viral
pathogens in a large set of bronchial alveolar lavage (BAL) fluid samples. The patterns of detected pathogens were
correlated to the clinical symptoms.
Methods: BAL fluid samples and clinical data were collected from 573 hospitalized children between 1 month and
14 years of age with LRTIs, enrolled from January to December 2018. Pathogens were detected using standardized
clinical diagnostics, with a sensitive, high-throughput GeXP-based multiplex PCR and with multiplex qPCR. Data
were analyzed to describe the correlation between the severity of respiratory tract disease and the pathogens
identified.
Results: The pathogen detection rate with GeXP-based PCR and multiplex qPCR was significantly higher than by
clinical routine diagnostics (76.09% VS 36.13%,χ2 = 8.191, P = 0.004). The most frequently detected pathogens in the
BAL fluid were human adenovirus (HADV)(21.82%), Mycoplasma pneumoniae (20.24%), human rhinovirus (13.96%),
Streptococcus pneumoniae (8.90%) and Haemophilus influenzae (8.90%). In 16.4% of the cases co-detection with two
or three different pathogens was found. Viral detection rates declined with age, while atypical pathogen detection
rates increased with age. Oxygen supply in the HADV and Influenza H1N1 infected patients was more frequent
(49.43%) than in patients infected with other pathogens.
Conclusion: Broad range detection of viral and bacterial pathogens using molecular methods is a promising and
implementable approach to improve clinical diagnosis and accurate treatment of LRTI in children.
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Background
Lower respiratory tract infections (LRTI) are the leading
cause of morbidity and mortality in children aged < 5
years worldwide [1]. Of the estimated 5.9 million deaths
in children younger than 5 years, pneumonia was found
to be the most important cause of death (16%) [2]. The
etiology is complex as a whole range of different patho-
gens, mainly viruses and bacteria, in different combina-
tions, can cause LRTI. Accurate detection of respiratory
tract pathogens is crucial for the clinical diagnosis and
for the epidemiology of LRTIs [3].
Bronchoalveolar lavage (BAL) has been considered the
gold standard for detection of the causative agents of
lower respiratory tract infections. However, BAL is only
performed in patients with complex or severe airway dis-
eases, e.g. children with chronic lung diseases, such as
cystic fibrosis, or recurrent LRTIs [4–6]. However, in the
literature, studies with a small number of inclusions [7,
8] or studies focused on a limited number of pathogens
can be found, focusing either only on viruses [4, 9] or on
bacterial pathogens [10]. However, large studies detect-
ing both viral and bacterial pathogens are needed to bet-
ter understand the cause-effect relation, the course of
disease and the level of severity to finally improve treat-
ment and accelerate the recovery from LRTI.
The utilization of molecular detection methods will re-
duce the turnaround time for diagnosis and will enable
the detection of more than one pathogen simultan-
eously. In this study, we detected a total of 21 different
pathogens: 11 viruses and 2 bacterial pathogens by
GeXP-PCR [11] and 8 bacterial pathogens by 2 in-house
qPCR assays [12] in BAL fluids from children admitted
to Shenzhen Children’s Hospital. The results on the mo-
lecular detection of the pathogens in the BAL fluid were
combined with the clinical characteristics of the patients
with LRTI rendering more insight into the causative
agents and diseases severity. Furthermore, this study
provides valuable data to improve treatment regimens
and to guide vaccine development strategies in China.
Materials and methods
Samples collection and information
Patients with complex or severe airway disease were en-
rolled in this study from January to December 2018. Pa-
tients eligible for BAL sampling were those with a
persistent chest radiographic infiltrate and/or persistent
respiratory symptoms, such as cough, wheezing, dys-
pnea, exacerbation, or unexplained hypoxemia. The col-
lection of BAL fluid was done within the Department of
Respiratory Diseases in Shenzhen Children’s Hospital for
pathogen identification using standardized clinical diag-
nostic assays, as described here below, to facilitate the
clinical decision for treatment. Furthermore, the same
samples were analyzed with two different PCR methods
(one for the detection of viral and atypical pathogens
and one for the detection of bacterial pathogens), as de-
scribed here below. Clinical and demographic data of
the patients enrolled in this study were retrieved from
the Shenzhen Children’s Hospital electronic patient dos-
siers. This study was approved by the Ethical Committee
of Shenzhen Children’s Hospital with registration num-
ber 2016013. Written informed consent was obtained
from the parents and caregivers of included children be-
fore study enrollment.
Standardized clinical diagnostics on BAL fluids
BAL fluids were collected from the infected part of chil-
dren with infection and/or the large airways of children
with persistent respiratory symptoms and sent to the
clinical lab for standardized diagnostic analyses within 2
h after sampling. Total DNA was extracted from 1mL of
BAL fluids, Mycoplasma pneumoniae was diagnosed
using the TaqMan probe PCR kit for M. pneumoniae
(DaAn Gene Co. Ltd., Guangzhou, China). We utilized
3 mL of BAL fluids to detect viruses, the D3 Ultra Direct
Immunofluorescence Assay (DFA) Respiratory Virus
Screening and ID Kit (Diagnostic hybrids, Inc., Athens,
Ohio, USA) was employed to detect respiratory syncytial
virus, adenovirus, influenza A/B virus and parainfluenza
virus (types 1, 2 and 3). We utilized 3 mL of BAL fluids
for bacterial culture. Bacterial culturing was conducted
to detect Acinetobacter baumannii, Haemophilus influ-
enzae, Haemophilus parainfluenzae, Moraxella catar-
rhalis, Staphylococcus aureus, Staphylococcus
haemolyticus and Streptococcus pneumoniae.
GeXP-based multiplex PCR and in-house qPCR on BAL
fluid samples
Total RNA/DNA was extracted from 300 μL respiratory
tract secretion using the TAN Bead Opti Pure Viral Auto
Tube (Taiwan Advanced Nanotech, Taiwan, China) on
Smart LabAssist-32 (Taiwan Advanced Nanotech, Taiwan,
China) according to the manufacturer’s instruction. The
extracts were eluted into 80 μL of DNase- and Rnase-free
water and then quantified using spectrophotometry. Plas-
mid pcDNA3.1 (+) (Thermo Fisher Scientific Co Ltd.,
Shanghai, China) was used as internal control. The GeXP-
based assay (Genome Lab GeXP Genetic Analysis System)
was performed on all BAL fluid samples for 13 different
respiratory pathogens: human adenovirus (HADV), Chla-
mydophila pneumoniae, coronaviruses (229E, OC43,
NL63 and HKU1), human metapneumovirus (HMPV),
human rhinovirus (HRV), human bocavirus (Boca), influ-
enza A (H3N2, H1N1, H5N2 and H7N9) and B viruses,
Mycoplasma pneumoniae, parainfluenza virus (types 1, 2,
3 and 4) and human respiratory syncytial virus (HRSV),
using the Respiratory Pathogens Multiplex Kit (PCR-Ca-
pillary Electrophoresis Fragment Analysis) (Health Gene
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Tech., Ningbo, China). The data was analyzed with the
Ge-XP system Software [11, 13]. In addition, we simultan-
eously performed semi-quantitative PCR detection on
adenovirus-positive specimens using the TaqMan probe
PCR kit for HADV (Shenzhen Puruikang Biotechnology
Co., Ltd., Shenzhen, China).
Bacterial loads were assessed by an in-house qPCR
assay for S. pneumoniae, H. influenzae, M. catarrhalis, S.
aureus, E. coli, K. pneumoniae, P. aeruginosa, and A.
baumannii and were expressed as colony forming unit
(CFU) equivalents per milliliter using standard curves
generated by target gene plasmid dilution series as previ-
ously described [12].
Statistical analysis
Statistical analyses were conducted using SPSS 19 (SPSS
Inc. Chicago, IL, USA). For comparison of categorical
data, chi-square or Fisher’s exact test was used.
Results
Patient characteristics
The median age of the 573 enrolled pediatric patients re-
quiring a BAL was 28months (interquartile range, 12 to
60), and the median length of hospital stay was 8 days
(interquartile range, 6 to 10). Male to female ratio of the
patients was 1.65:1. The majority of patients (82.6%) had
a radiologically confirmed pneumonia and persistent re-
spiratory symptoms (17.5%). A total of 192 patients
(33.5%) required oxygen supply and 5 (0.9%) required in-
vasive mechanical ventilation (Table 1). None of the pa-
tients were admitted to the ICU.
The 573 patients were divided in four age groups: in-
fants (1–12months, 168 cases), toddlers (~ 3 years old,
162 cases), preschool children (~ 6 years old, 132 cases)
and school children (~ 14 years old, 111 cases). No sig-
nificant differences in the prevalence of LRTI were
found between the age groups (Table 1).
Pathogen detection using standardized clinical diagnostic
tests
In 207 out of 573 samples (36.1%) one or more patho-
gens were detected. In 87 samples (15.2%) 2 or more
pathogens were detected, strongly suggesting that these
patients had a co-detection. The most common patho-
gens detected by routine clinical laboratory diagnostics
were M. pneumoniae (in 20.2% of the patients), by a
clinically validated PCR, S. pneumoniae (5.76%) and H.
influenzae (3.1%) by culture, and human adenovirus
(3%) by DFA (Supplementary Table 1).
Pathogen detection by GeXP-based multiplex PCR and
qPCR
A total of 436 BALFs (76.1%) were positive for at least
one pathogen, of which 19.9% had a co-detection. The
most frequently detected pathogens using these PCR-
based methods were HADV (21.8%), M. pneumoniae
(20.2%), HRV (14%), S. pneumoniae (8.9%) and H. influ-
enzae (8.9%), followed by HRSV (5.8%), HPIV (4.9%), M.
catarrhalis (4.5%), HMPV (3.1%), Boca (2.4%), H1N1
(2.4%), S. aureus (1.6%) and HCOV (1.2%) (Fig. 1).
A total of 198 patients (34.6%) were infected with vi-
ruses only, while 55 (9.6%) were infected with bacterial
pathogens. Co-detection with 2 or 3 different pathogens
was found in 94 patients (16.4%)(Fig. 2).
Although this study included more male patients
(62.3%) than female patients (37.7%), infection rates
were comparable males (76.2%) and females (75.9%)
(χ2 = 0.005, p = 0.943). Detection rates in different age
groups were not significantly differently: 1–12months:
73.81%, 1–3 years: 80.86%, 4–7 years: 74.24% and 8–14
years: 74.77% (χ2 = 2.863, p = 0.413). In general, viral
lower respiratory tract infection rates declined with age,
while infection with atypical pathogen rates increased
with age. Bacterial infection of the lungs peaked during
infancy. HADV and S. pneumoniae were detected more
commonly in children younger than 6 years old, while
M. pneumoniae detection rate increased with age signifi-
cantly (Fig. 3).
Of all pathogens identified, M. catarrhalis showed the
highest co-detection rate (84.6%). Bacterial co-detection
rates were higher than viral co-detection rates (Fig. 4).
Comparison of pathogen detection in children with and
without pneumonia
The detection rate of pathogens in children with pneu-
monia (78.4%, 371/473) was significantly higher than in
children without pneumonia (65.0%, 65/100, χ2 = 8.191,
P = 0.004). The majority of atypical pathogens were de-
tected in children with pneumonia, while more bacterial
pathogens were detected in the non-pneumonia than in
the pneumonia group (Fig. 5). HADV and M. pneumo-
niae were more frequently detected in BAL samples
from children with pneumonia, H. influenzae was more
often detected in children without pneumonia (Fig. 5).
The causative agents were missed by routine laboratory
tests in children requiring BAL
The overall detection rate of pathogens by GeXP-based
assay and multiplex qPCR (76.1%) was significantly
higher than that by clinical laboratory tests (36.1%). In
addition, the GeXP-based PCR has a much broader de-
tection range and included Chlamydophila pneumoniae
human rhinovirus (HRV), HMPV, HCOV and Boca
virus. The sensitivity of GeXP-based assay was similar to
single qPCR. The detection rates of GeXP-based assay
were significantly higher than with DFA; HADV (21.8%
vs 3%), HRSV (5.8% vs 2.6%), HPIV (4.9% vs 0.9%)and
INFA/B (3% vs 0.52%). In those cases that HADV was
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detected as a single pathogen the Ct values were signifi-
cantly lower than when co-detected with other pathogens,
median values of HADV as single pathogen and when co-
detected with other pathogens were Ct 20.35 and Ct
29.45, respectively (supplementary Table 2A and 2B). The
DFA was more likely to be positive when the Ct values
were lower. Bacterial detection rates by qPCR were higher
than culture, but there was no significant difference be-
tween these two assays (Supplementary Table 1).
The correlation between single pathogen detected in the
BAL fluids and clinical signs
We divided the single pathogen-infected children into 3
groups according to pathogen (atypical, viral and bacter-
ial pathogens) and analyzed the relation between respira-
tory diseases and pathogens, M. pneumoniae (85 cases),
virus (171 cases), H. influenzae or S. pneumoniae (37
cases). As demonstrated in Table 2, fever, oxygen supply,
WBC (white blood cell), Neutrophil counts, CRP (C-re-
active protein), PCT (procalcitonin) were statistically dif-
ferent among groups of bacteria, mycoplasma and virus.
The fever rate of patient infected with M. pneumoniae
was significantly higher than bacterial or viral infection.
More patients infected with virus needed oxygen supply.
Discussion
Due to the invasive nature of bronchoscopy, data on the
presence of pathogens in the lower airways are very
scarce. A unique set of 573 BAL fluid samples was col-
lected in children between January and December in
2018, in Shenzhen, Southern China. This allowed us for
the first time to study the presence of pathogens in the
lower respiratory tract on a relatively large scale. Fur-
thermore, this study has enabled us to compare the
Table 1 Clinical and demographic characteristics of the patients included in this study
Characteristics Children requiring bronchoalveolar lavage (Total number = 573) (%)
Age (months)








Asthma or allergic diseases 110 (19.2)





Diagnosis based on Chest X-ray or CT scan
Pneumonia 442 (77.1)
Atelectasis (partial or complete) 116 (20.2)




Median length of stay 8 days
Mechanical ventilation 5 (0.9)
Oxygen absorption 192 (33.5)
Antibiotic treatment 524 (91.5)
Antiviral treatment 76 (13.3)
Time of bronchoscopy
Median time post-admission 4 days
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routine clinical diagnostics with a new PCR-based diag-
nostics approach.
PCR-based diagnostics resulted in detection of respira-
tory pathogens in 76.1% of all cases. A similar percent-
age (78.7%) as was previously found in a smaller study
recently conducted in Zhengzhou (Northern China)
[10], but higher than previously found in studies per-
formed in Suzhou and Shanghai (Eastern China) [3, 14].
While the routine clinical diagnostics approach in this
study resulted in the detection of respiratory pathogens
in 36.1%. Which clearly indicates that PCR-based detec-
tion is far more sensitive than the routine clinical diag-
nostics as currently applied. PCR-based detection also
revealed that co-detection was found in 16.4%. Most
prevalent of all co-detections were viral-bacterial co-
detections (11.2%). The co-detection rate was lower than
that in Zhengzhou (30.6%) and similar to that in Shang-
hai (11.4%), also determined by PCR-based detection.
Interestingly, HADV and M. pneumoniae showed
similar clinical characteristics, including the fact that
90% of patients infected with these pathogens developed
fever. However, the median age of children infected with
HADV, was significantly younger than children infected
with M. pneumoniae. Strikingly, this study confirms that
HADV is a common pathogen in Southern China
(Guangzhou, Hunan) as high prevalence was earlier found
in other studies conducted in the same region [15, 16].
This was not the case for other areas in China, which is
concluded based on studies conducted in Suzhou and
Chongqi [17, 18]. However, M. pneumoniae seems highly
prevalent in different parts of China. This striking regional
difference within China demands for further study.
Fig. 1 Percentages of viral and bacterial pathogens detected in 573 BAL fluids, including single- and co-detection, ‘other’ includes HCoV, INFB, C.
pneumoniae, Klebsiella pneumoniae, Pseudomonas aeruginosa, Escherichia coli, and Acinetobacter baumannii
Fig. 2 Detection rates of the different pathogen groups (viral, bacterial, atypical, co-detection, no pathogen) based on age. The atypical
pathogens include M. pneumoniae and C. pneumoniae
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HRV was detected in 13.96% of the patients and was
the most common pathogen in patients with severe
pneumonia. HRV was more often co-detected with other
pathogens than found as single pathogen.
H. influenzae and S. pneumoniae were the most com-
mon bacterial causes of LRTIs. H. influenzae is often
found in patients with chronic cough and protracted
bacterial bronchitis (PBB) [19]. We found H. influenzae
was more detected in children without pneumonia in
this study, this might be due to the selection of patients
and the number of cases. The qPCR method for detec-
tion of bacterial pathogens was more sensitive than bac-
terial culture.
Strikingly not RSV but HADV was the most im-
portant viral pathogen in this study as opposed to
previous studies [15, 20]. This could be explained by,
method of detection, study population and geograph-
ical location.
Fig. 3 Age-dependent infection rates with specific pathogens detected in BAL fluids. ‘other’ includes HCoV, INFB, Chlamydophila pneumoniae,
Staphylococcus aureus, Klebsiella pneumoniae, Pseudomonas aeruginosa, Escherichia coli, and Acinetobacter baumannii
Fig. 4 Specific combinations of pathogens identified in BAL fluid from pediatric patients with lower respiratory tract infections. Abbreviations in
the figure: Mycoplasma pneumoniae (Mp), Chlamydia (CH), Haemophilus influenzae (Hi), Strepcoccus pnemoniae (Sp), Moraxella catarrhalis (Mc),
Staphylococcus aureus (Sa), Klebsiella pneumoniae (Kp), Pseudomonas aeruginosa (Pa), Escherichia coli (Ec), and Acinetobacter baumannii (Ab)
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Fig. 5 Specific pathogens were detected in BAL fluids between pneumonia group and non-pneumonia group. ‘other’ includes HCoV, INFB,
Chlamydophila pneumoniae, Staphylococcus aureus, Klebsiella pneumoniae, Pseudomonas aeruginosa, Escherichia coli, and Acinetobacter baumannii
Table 2 Clinical symptoms and treatments. Data are median (IQR), n (%), or n/N (%). The p values were calculated by Kruskal-Wallis





Viral infection p value
Fever
0 22 (59.5) 6 (7.1) 49 (28.7) < 0.001
1 15 (40.5) 79 (93) 122 (71.4)
Cough
0 5 (13.5) 3 (3.5) 9 (5.3) 0.0854
1 32 (86.5) 82 (96.5) 162 (94.7)
Oxygen supply
0 33 (89.19) 64 (75.29) 95 (55.6) < 0.001
1 4 (10.81) 21 (24.71) 76 (44.4)
Antibiotics
0 1 (2.7) -(−) 2 (1.2) 0.3783
1 36 (97.3) 85 (100) 169 (98.8)
Antiviral treatment
0 33 (89.2) 77 (90.6) 139 (81.3) 0.1088
1 4 (10.8) 8 (9.4) 32 (18.7)
Steriod treatment
0 20 (54.1) 39 (45.9) 103 (60.2) 0.0927
1 17 (45.9) 46 (54.1) 68 (39.8)
Neutrophils
0 14 (37.8) 39 (45.9) 59 (34.5) 0.2105
1 23 (62.2) 46 (54.1) 112 (65.5)
Hospitalisation days 7 (6.0–9.0) 8 (7.0–10.0) 8 (6.0–11.0) 0.0976
WBC (× 109/L) 10.98 (9.08–14.42) 6.58 (5.5–8.6) 9.58 (6.96–14.1) < 0.001
CRP (mg/L) 3.8 (0.5–12.8) 14.9 (5.4–34) 4.5 (0.1–16.1) < 0.001
PCT (μg/L) 0.2 (0.1–1.0) 0.19 (0.1–0.3) 0.17 (0.1–0.9) 0.001
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This study has some limitations. Firstly, none of the
diagnostic methods was able to detect fungal pathogens,
while fungi might be important pathogens of LRTIs in
part of the patients. Secondly, we cannot exclude that
we might have missed some of the RNA viruses because
of RNA degradation during storage and sample process-
ing. Thirdly, the amount of fluid retrieved and sampling
conditions could have influenced the detection rate.
Fourth, in 10.3% of the children the BAL sample was
taken more than 1 week after admission because of dif-
ferent reasons. A combination of the above mention fac-
tors could possibly explain why in 23,9% of the cases no
viral or bacterial pathogen was found. Nevertheless, the
molecular methods used in this study significantly in-
creased the diagnostic accuracy (from 36.1 to 76.1%).
In conclusion, lower respiratory tract infections are
complex with a diverse clinical phenotype and are
caused by many different pathogens. We found that vi-
ruses were the major pathogens detected in the BAL
fluids. Viral and bacterial pathogens were detected more
frequently in younger children. This study gave us
insight into the etiology of LRTI in children from differ-
ent ages from Southern China and will help to improve
the diagnosis. GeXP-based multiplex PCR with a much
broader range of pathogen detection clearly showed to
be superior than the routine laboratory diagnostic
methods, showing promise for the near future of LRTI
diagnostics.
Conclusions
HADV, rhinovirus and Mycoplasma pneumoniae are the
most important causes of severe LRTI in children in the
south of China. Viral detection rates declined with age,
while atypical pathogen detection rates increased with
age. These promising molecular methods of pathogen
detection will be implemented to improve clinical diag-
nosis and accurate treatment of LRTI in children.
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